Marchex, Inc. (NASDAQ:MCHX) Q4 2022 Earnings Conference Call February 28, 2023 5:00 PM ET Company Participants Trevor Caldwell - Investor Relations Edwin Miller - CEO Michael Arends - Vice Chairman Conference Call Participants Dillon Heslin - ROTH Capital Partners Mike Latimore - Northland Capital Market Operator Good afternoon, ladies and gentlemen. Thank you for joining today's Marchex???s Fourth Quarter Earnings Conference Call. My name is Tia and I will be your moderator for today's call. [Operator Inst ...

Marchex, Inc. (NASDAQ:MCHX) Q3 2022 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants Trevor Caldwell - Investor Relations Michael Arends - Co-Chief Executive Officer Russell Horowitz - Co-Chief Executive Officer Conference Call Participants Dillon Heslin - ROTH Capital Partners Vivek Palani - JMN Research Operator Good afternoon, everyone, and welcome to the Marchex???s Third Quarter Conference Call. My name is Emily and I will be your conference call operator today. [Operator Instr ...

Revenue Performance - For the nine months ended September 30, 2022, revenue was $39.9 million, a decrease of $808,000, or 2%, compared to $40.7 million for the same period in 2021[90] - The decrease in revenue is primarily due to lower conversational volumes compared to the recovery period in 2021, along with ongoing impacts from COVID-19 variants, supply chain disruptions, inflation, and labor shortages[90] - Revenue decreased by $808,000 or 2%, from $40.7 million for the nine months ended September 30, 2021 to $39.9 million for the same period in 2022[104] - The company expects revenues to be slightly lower in the near term due to reduced seasonal call volume, particularly in the latter part of the fourth quarter[105] - The company expects revenues to recover if macroeconomic conditions improve and business interruptions subside, but potential disruptions from COVID-19 and supply chain issues could lower revenues[127] Operating Expenses - Service costs decreased by $1.6 million or 10%, from $16.4 million for the nine months ended September 30, 2021 to $14.8 million for the same period in 2022, representing 40% and 37% of revenue respectively[108] - Product development expenses decreased by $2.8 million or 21%, from $13.3 million for the nine months ended September 30, 2021 to $10.5 million for the same period in 2022, accounting for 33% and 26% of revenue respectively[114] - General and administrative expenses increased by $413,000 or 6%, from $7.0 million for the nine months ended September 30, 2021 to $7.4 million for the same period in 2022, representing 17% and 19% of revenue respectively[117] - Stock-based compensation expense totaled $2.034 million for the nine months ended September 30, 2022, compared to $2.007 million for the same period in 2021[103] - The company anticipates stable to modestly higher expenditures for product development initiatives in the near and intermediate term[129] Financial Position - The net loss for the nine months ended September 30, 2022, was $4.7 million, an increase from a net loss of $2.4 million for the same period in 2021[124] - Cash used in operating activities was $1.8 million for the nine months ended September 30, 2022, compared to $5.8 million for the same period in 2021[126] - Cash used in investing activities increased to $2.0 million for the nine months ended September 30, 2022, from $504,000 in the same period in 2021[128] - Cash provided by financing activities was $30,000 for the nine months ended September 30, 2022, down from $252,000 in the same period in 2021[130] - The company had cash and cash equivalents of $23.3 million as of September 30, 2022, down from $27.1 million as of December 31, 2021[125] - Long-term contractual obligations as of September 30, 2022, totaled $4.9 million, including $2.0 million for rent under facility operating leases[125] - The company believes its resources will be sufficient to fund operations for at least twelve months, but additional financing may be needed for acquisitions and long-term obligations[131] Strategic Initiatives - Marchex's primary product offerings include Marchex Call Analytics, which helps businesses optimize advertising expenditures and measure call outcomes[80] - Marchex launched Marchex Conversation DNA in March 2022, enabling voice and text conversation decoding and scoring across its products, utilizing over one billion minutes of voice conversations[89] - Marchex plans to expand its conversational intelligence technology and invest in AI, data science, and machine learning capabilities[83] - The company aims to grow its customer base by integrating its products with existing communication providers, enhancing accessibility for businesses[84] - Marchex is pursuing selective acquisition opportunities to enhance its strategic position and increase shareholder value[85] - The company continues to focus on improving marketing performance through its conversational analytics solutions, which received the MarTech Best Marketing Attribution Solution award in 2021[81] Market Outlook - The global conversational AI market is projected to grow at a compounded annual growth rate of 22%, from $6.8 billion in 2021 to $18.4 billion by 2026[81] - The company anticipates volatility in results due to the ongoing impacts of the coronavirus pandemic and macroeconomic conditions[105] - The company believes new product releases and growth initiatives may provide opportunities for potential revenue growth in the longer term[106] Tax and Valuation - As of September 30, 2022, the company recorded a 100% valuation allowance of $54.7 million against its net deferred tax assets, compared to $53.0 million at December 31, 2021[123] - Amortization of intangible assets from acquisitions was $3.7 million for the nine months ended September 30, 2021, decreasing to $1.6 million for the same period in 2022[120] - Interest income decreased significantly from $2.5 million for the nine months ended September 30, 2021 to $33,000 for the same period in 2022[121] Lease Accounting - The company has elected the short-term lease recognition exemption for all qualifying leases, meaning no ROU assets or lease liabilities are recognized for these leases[154] - Operating lease ROU assets and liabilities are recognized at commencement based on the present value of lease payments over the lease term[153] - The company primarily leases office facilities classified as operating leases and does not have finance leases[153] - Lease payments included in the measurement of lease liability are comprised of fixed payments[153] - The company uses its incremental borrowing rate to determine the present value of lease payments as the implicit interest rate is not readily determinable[153] - The lease term includes the non-cancellable period of the lease, with options for lease renewals excluded from the lease term[153] Investor Relations - The company provides access to its financial reports and material information through its investor relations website and social media channels[156] - As a smaller reporting company, the company is not required to provide quantitative and qualitative disclosures about market risk[157]

Marchex, Inc. (NASDAQ:MCHX) Q2 2022 Results Conference Call August 9, 2022 5:00 PM ET Company Participants Trevor Caldwell - Senior Vice President-Strategic Initiatives and Investor Relations Michael Arends - Co-Chief Executive Officer Russell Horowitz - Co-Chief Executive Officer Conference Call Participants Austin Vetterick - ROTH Capital Partners Operator Good afternoon. Thank you for attending today's Marchex' Second Quarter Earnings Conference Call. My name is Tamia, and I will be your moderator for to ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marchex, Inc. (Exact name of Registrant as specified in its charter) Delaware 35-2194038 (State or other jurisdiction of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marchex, Inc. (Exact name of Registrant as specified in its charter) Delaware 35-2194038 (State or other jurisdiction of ...

Marchex, Inc. (NASDAQ:MCHX) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants Trevor Caldwell ??? Senior Vice President-Strategic Initiatives and Investor Relations Michael Arends ??? Co-Chief Executive Officer Russell Horowitz ??? Executive Chairman and Office of the Chief Executive Officer Conference Call Participants Operator Good afternoon. And thank you for attending today's Marchex First Quarter 2022 Earnings Call. My name is Jayson, and I will be your moderator for the cal ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-50658 Marchex, Inc. | (Exact name of Registrant as specified in its Charter) | | --- | | Delaware | 35-2194038 | | --- | --- | | (Sta ...

Marchex, Inc. (NASDAQ:MCHX) Q4 2021 Earnings Conference Call March 2, 2022 5:00 PM ET Corporate Participants Trevor Caldwell - Senior Vice President, Strategic Initiatives and Investor Relations Michael Arends - Chief Financial Officer and Office of the CEO Russell Horowitz - Executive Chairman and Office of the CEO Conference Call Participants Darren Aftahi - ROTH Capital Partners Sharon Kiruba - Northland Capital Markets Operator Ladies and gentlemen, good afternoon and thank you for attending today's Mar ...

Marchex, Inc. (NASDAQ:MCHX) Q3 2021 Earnings Conference Call November 9, 20210 5:00 PM ET Company Participants Trevor Caldwell - Senior Vice President, Strategic Initiatives and Investor Relations Michael Arends - Co-Chief Executive Officer Russell Horowitz - Executive Chairman and Co-CEO Leila Kirske - Chief Financial Officer Conference Call Participants Austin Vetterick - ROTH Capital Partners Operator Hello and welcome to the Marchex???s Third Quarter Earnings Conference Call. My name is Charlie and I wi ...